• Skip to main content
  • Skip to primary sidebar

Experienced Indiana Law Firm | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad, LLP | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad is rated highly on Google Reviews by clients.
Toll Free866.446.7478Toll Free317.636.6481
Make a Payment free consult
  • English
  • Español

Search

  • About Us
  • Attorneys
  • Services
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    • Español

Taxotere

Home » Practice Areas » Pharmaceutical Drug And Medical Device Litigation » Taxotere

Taxotere Permanent Hair Loss Lawsuits

Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi Aventis and used in the treatment of breast cancer, lung cancer, prostate cancer, stomach cancer and head & neck cancer. It works by interfering with the growth of cancer cells.

Taxotere associated with permanent hair loss

The FDA issued a safety announcement in December 2015 for Taxotere citing a number of adverse event reports of permanent alopecia or hair loss. Many patients undergoing chemotherapy treatments for cancer are told of a possible temporary hair loss, however, patients undergoing chemotherapy treatment with Taxotere were unaware of the potential for permanent hair loss. This can be particularly devastating to women. Permanent hair loss can have a significant psychological impact on patients.

In 2013, researchers gathered data from patients who received chemotherapy treatment using Taxotere during 2010. Findings of the survey data indicated 15% of respondents experienced significant persistent scalp hair loss. Patient advocate organization A Head of Our Time reported a study conducted by Dr. Scot Sedlacek, an oncologist at the Rocky Mountain Cancer Centers in Denver, Colorado conducted a study in 2006 that found as many as 6% of his study group who received Taxotere in chemotherapy treatment experienced permanent hair loss or alopecia.

Taxotere hair loss lawsuits

Permanent hair loss can have a devastating psychological impact on chemotherapy patients. It can stand as a life-long reminder of cancer and negatively impact self-esteem as well as contribute to depression and other mental health issues. Many patients who experience Taxotere alopecia claim Sanofi Aventis failed to warn them and their healthcare providers that permanent hair loss could occur if they are prescribed Taxotere for chemotherapy treatment of cancer.

CohenMalad, LLP product liability attorneys are interested in talking with people who have taken Taxotere and suffered permanent alopecia. Our attorneys have litigated hundreds of claims against large pharmaceutical companies and medical device manufacturers. Contact us for a free case evaluation.

Primary Sidebar

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.

CohenMalad, LLP

One Indiana Square Suite 1400
Indianapolis, Indiana 46204
317.636.6481
Toll Free: 866.446.7478
  • twitter logo

Copyright © 2025 CohenMalad, LLP
Disclaimer Privacy Policy

  • About Us
  • Attorneys
  • Services
    â–¼
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    â–¼
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    â–¼
    • Español
Cookies and other technology are used on this website to tailor your user experience and evaluate our marketing strategy. By clicking any link on this site you agree to our privacy policy.
En este sitio web utilizamos cookies y otras tecnologías para personalizar su experiencia de usuario y evaluar nuestra estrategia de marketing. Al hacer clic en cualquier enlace de esta plataforma, usted acepta nuestra política de privacidad.
Agree